Filter Results
:
(517)
Show Results For
-
All HBS Web
(517)
- People (1)
- News (182)
- Research (228)
- Events (1)
- Multimedia (3)
- Faculty Publications (55)
Show Results For
-
All HBS Web
(517)
- People (1)
- News (182)
- Research (228)
- Events (1)
- Multimedia (3)
- Faculty Publications (55)
- 01 Jun 2008
- News
HBS Creates Life Sciences Fellowship Fund
Next fall’s entering MBA Class of 2010 will include up to ten students who have received $20,000 fellowships based on their academic or professional excellence in the field of life sciences. Financial support from the Life Sciences Fellowship View Details
- 06 Sep 2005
- Research & Ideas
The Best Place for Retirement Funds
or an equity mutual fund that holds low-dividend stocks and passes through little in the way of realized capital gains. A high-tax asset might be a standard corporate bond, since the interest payments on a bond held in a taxable account...
View Details
Keywords:
by Ann Cullen
- June 2012 (Revised October 2018)
- Case
Home Nursing of North Carolina
By: Richard S. Ruback and Royce Yudkoff
Ari Medoff's (HBS '11) goal was to control his own professional destiny by owning his own company. His search identified a suitable acquisition in Home Nursing of North Carolina, and he had negotiated a purchase price of $3.5 million, or 4.2x trailing EBITDA. Medoff...
View Details
Keywords:
Search Funds;
Small Companies;
Acquisitions;
Negotiation;
Medical Services;
Negotiation Process;
Valuation;
Investment;
Acquisition;
Health Industry
Ruback, Richard S., and Royce Yudkoff. "Home Nursing of North Carolina." Harvard Business School Case 212-120, June 2012. (Revised October 2018.)
- 11 Nov 2015
- Working Paper Summaries
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules
- Web
Financial Aid - HBS Fund Investors Society 2021 Report
explains Rabah, who is now a proud citizen. “We were afraid of ending up with huge medical bills we couldn’t pay.” Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without...
View Details
- Web
University Collaborations - HBS Fund Investors Society 2021 Report
between Harvard Medical School and the Faculty of Arts and Sciences. Students complete HBS’s MBA Required Curriculum, science courses, and special courses designed specifically for the MS/MBA program. For example, Frontiers in...
View Details
- Web
Investors Society Report - HBS Fund Investors Society 2021 Report
HBS Fund Investors Society 2021 Report Thank You. As a member of the HBS Fund Investors Society in fiscal year 2021 (July 1, 2020–June 30, 2021), you fueled Harvard Business School’s efforts to educate...
View Details
- March 2015
- Teaching Note
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
Keywords:
Medication Adherence;
Affordable Care Act (ACA);
Marketing Strategy;
Communication Strategy;
Customer Value and Value Chain;
Decisions;
Health Care and Treatment;
Goals and Objectives;
Resource Allocation;
Marketing Communications;
Consumer Behavior;
Measurement and Metrics;
Service Delivery;
Behavior;
Motivation and Incentives;
Social Issues;
Information Technology;
Value Creation;
Health Industry;
Pharmaceutical Industry;
Insurance Industry;
Public Relations Industry;
Retail Industry;
United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Teaching Note 515-086, March 2015. (Email mking@hbs.edu for a courtesy copy.)
- Web
Student Startups Help Fight COVID-19 - HBS Fund Investors Society 2020 Report
and serves as chief medical officer. Before the pandemic developed, Umbulizer’s affordable device was already in use in hospitals and mobile medicine settings in Pakistan, supplementing the country’s limited supply of just 2,000...
View Details
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
Dean Nitin Nohria has announced that the Bertarelli Foundation of Switzerland, cochaired by Ernesto Bertarelli (MBA 1993), has established the Bertarelli Foundation Health & Life Sciences Entrepreneurship Fund with a generous gift to...
View Details
- Web
Fostering Innovation in Social Enterprise Across Harvard - HBS Fund Investors Society 2020 Report
HBS, Harvard Kennedy School (HKS), Harvard Medical School, and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS)—to set up a foundation alongside their company to maximize their impact as a social enterprise....
View Details
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords:
Health Care;
Health Care Industry;
Health Care Policy;
Health Services;
Healthcare;
Healthcare Reform;
Healthcare Ventures;
Nonprofit;
Non-profit Management;
Not-for-profit;
Incubator;
Accelerator;
Venture Philanthropy;
Medical Services;
Medical Solutions;
Medical Research;
Medical Treatment;
Clinical Trials;
Drug Reimbursement;
Early Stage;
Early Stage Research Funding;
Early Stage Funding;
Milken Institute;
Michael Milken;
David Baltimore;
Partnering For Cures;
National Institutes Of Health;
Cancer Care In The U.S.;
Cancer Care Services;
Policy-making;
Health Care and Treatment;
Health;
Health Testing and Trials;
Entrepreneurship;
Social Entrepreneurship;
Nonprofit Organizations;
Policy;
Health Industry;
United States;
District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire...
View Details
Keywords:
CV Ingenuity;
CVI;
Drug Eluting Balloon;
DEB;
Drug Eluting Stent;
Angioplasty Balloon;
FoxHollow;
Medical Device;
Medical Device Startup;
Premarket Approval;
PMA;
Lutonix;
Stellarex;
LEVANT;
ILLUMENATE;
Clinical Trials;
Peripheral Arterial Disease;
PAD;
Healthcare Startups;
Covidien;
Health Care and Treatment;
Health Testing and Trials;
Business Startups;
Commercialization;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
United States;
Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- 22 Feb 2022
- News
Elevator Pitch: Good Vibrations
won’t take those medications due to side effects. There’s a real gap for a simple treatment you can use earlier in the disease trajectory.” Status Update: The grand prize winner in the Alumni New Venture Competition, Bone Health...
View Details
- March 2015 (Revised February 2022)
- Supplement
CV Ingenuity (B): Epilogue
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors?
The...
View Details
Keywords:
CV Ingenuity;
CVI;
Drug Eluting Balloon;
DEB;
Drug Eluting Stent;
Angioplasty Balloon;
FoxHollow;
Medical Device;
Medical Device Startup;
Premarket Approval;
PMA;
Lutonix;
Stellarex;
LEVANT;
ILLUMENATE;
Clinical Trials;
Peripheral Arterial Disease;
PAD;
Healthcare Startups;
Covidien;
Health Care and Treatment;
Health Testing and Trials;
Business Startups;
Commercialization;
Strategy;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
United States;
Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (B): Epilogue." Harvard Business School Supplement 315-087, March 2015. (Revised February 2022.)
- Awards
Strategy Research Foundation (SRF) Dissertation Research Grant
Recipient of a 2014 Strategy Research Funding (SRF) Grant from the Dissertation Research Program for "Waiting to Inhale: How Medical Cannabis Entrepreneurs are Legitimating a Stigmatized Industry."
View Details
- 13 Apr 2023
- HBS Seminar
Bhaven Sampat, Columbia
- 23 Jan 2018
- Video
Dr. Marlene Krauss: Health Care Visionary
- October 2020
- Case
LifeBank Nigeria
By: Brian Trelstad, Pippa Tubman Armerding and Wale Lawal
The aspiration of addressing maternal deaths in Nigeria, which were mostly caused by blood shortages, led Temie Giwa-Tubosun to found LifeBank in 2015. LifeBank developed an online platform that enabled hospitals to connect and purchase blood from local blood banks and...
View Details
Keywords:
Systems Design;
Social Business;
Business At The Base Of The Pyramid;
Health Care;
Blood;
Social Enterprise;
Health Care and Treatment;
Growth and Development Strategy;
Finance;
Health Industry;
Transportation Industry;
Africa;
Nigeria
Trelstad, Brian, Pippa Tubman Armerding, and Wale Lawal. "LifeBank Nigeria." Harvard Business School Case 321-082, October 2020.